Literature DB >> 11692116

Emergency department anaphylaxis: A review of 142 patients in a single year.

A F Brown1, D McKinnon, K Chu.   

Abstract

BACKGROUND: There are few data on the incidence, clinical features, and management of patients with acute anaphylaxis presenting to the emergency department. We investigated all presentations to one department during the course of a year to improve current awareness of this medical emergency.
OBJECTIVE: The purpose of the study was to describe the clinical features, management, and outcome of anaphylaxis presentations to a single Australian adult emergency department in a single year, 1998-1999.
METHODS: This was a retrospective, case-based study of adult patients (>or=13 years of age) attending a single emergency department in Brisbane, Australia, during the year 1998-1999. The medical records of 304 patients satisfying the relevant discharge diagnostic codes were studied. We determined incidence, sex ratio, age, clinical features, management, disposal, asthma prevalence, and causes in patients presenting with acute allergic reactions and anaphylaxis.
RESULTS: In all, 162 emergency department patients with acute allergic reactions and 142 emergency department patients with anaphylaxis, including 60 whose anaphylaxis was severe, were seen during the year, for an anaphylaxis presentation incidence of 1 in 439. One patient died; this gave a case fatality rate of 0.70%. Cutaneous features were present in 94% of the patients with anaphylaxis. Of those with severe anaphylaxis, 35% had dizziness/syncope before hospital presentation, 25% laryngeal edema, and 21.7% systolic hypotension on hospital presentation. A cause was recognized in 73% of the anaphylaxis cases; most commonly, the causative agent was a drug, insect venom, or food. Adrenaline was used in 57% of the severe cases before hospital presentation or in the hospital. The emergency department alone definitively cared for 94% of all patients, though only 43% severe anaphylaxis cases were referred for follow-up.
CONCLUSION: The emergency department anaphylaxis presentation incidence of 1 in 439 cases is greater than previously recognized, though death remains rare. In three fourths of cases, a precipitant was identified, a fact that emphasizes the need for a detailed initial history. Definitive management in the emergency department alone is possible in most cases, provided that the appropriate use of adrenaline and the need for allergy clinic follow-up are appreciated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692116     DOI: 10.1067/mai.2001.119028

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  54 in total

1.  [Not Available].

Authors:  A Cheng
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

Review 2.  Critical care in the emergency department: shock and circulatory support.

Authors:  C A Graham; T R J Parke
Journal:  Emerg Med J       Date:  2005-01       Impact factor: 2.740

Review 3.  8 management of allergy, rashes, and itching.

Authors:  M Langran; C Laird
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

4.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

6.  Paediatric emergency department anaphylaxis: different patterns from adults.

Authors:  S C Braganza; J P Acworth; D R L Mckinnon; J E Peake; A F T Brown
Journal:  Arch Dis Child       Date:  2005-11-24       Impact factor: 3.791

7.  Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.

Authors:  Tiansheng Wang; Xiang Ma; Yan Xing; Shusen Sun; Hua Zhang; Til Stürmer; Bin Wang; Xiaotong Li; Huilin Tang; Ligong Jiao; Suodi Zhai
Journal:  Int Arch Allergy Immunol       Date:  2017-05-16       Impact factor: 2.749

Review 8.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

9.  Navigating the updated anaphylaxis parameters.

Authors:  Stephen F Kemp
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

Review 10.  Anaphylaxis caused by intravenous fluorescein: clinical characteristics and review of literature.

Authors:  Sang Ook Ha; Dae Yong Kim; Chang Hwan Sohn; Kyoung Soo Lim
Journal:  Intern Emerg Med       Date:  2013-11-30       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.